Collins Helen Louiseinsider trades
In SEC Form 4 filings, Collins Helen Louise is listed as CHIEF MEDICAL OFFICER of Enliven Therapeutics, Inc. (ELVN). In the last 90 days, Collins Helen Louise sold $444.1K of Enliven Therapeutics, Inc. (ELVN) on the open market and bought none. All 4 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ELVNEnliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | 8 | Oct 21 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-21
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ELVNEnliven Therapeutics, Inc. | Oct 19 | Oct 21 | M | 5,000 | $2.48 | $12,400 | 30,000 | Yes | Form 4 |
| ELVNEnliven Therapeutics, Inc. | Oct 19 | Oct 21 | S | 5,000 | $38.47 | Sale −$192,342 | 25,000 | Yes | Form 4 |
| ELVNEnliven Therapeutics, Inc. | Oct 19 | Oct 21 | M · derivative | 5,000 | $2.48 | $12,400 | 101,268 | Yes | Form 4 |
| ELVNEnliven Therapeutics, Inc. | Sep 17 | Sep 21 | M | 5,000 | $2.48 | $12,400 | 30,000 | Yes | Form 4 |
| ELVNEnliven Therapeutics, Inc. | Sep 17 | Sep 21 | S | 2,916 | $50.03 | Sale −$145,891 | 27,084 | Yes | Form 4 |
| ELVNEnliven Therapeutics, Inc. | Sep 17 | Sep 21 | S | 1,844 | $50.71 | Sale −$93,507 | 25,240 | Yes | Form 4 |
| ELVNEnliven Therapeutics, Inc. | Sep 17 | Sep 21 | S | 240 | $51.48 | Sale −$12,356 | 25,000 | Yes | Form 4 |
| ELVNEnliven Therapeutics, Inc. | Sep 17 | Sep 21 | M · derivative | 5,000 | $2.48 | $12,400 | 106,268 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.